Skip to main content
Signal8

Innovative Immunology Biotech Windward Bio Lists on Nasdaq

$WWBPress releaseNov 14, 2026, 10:58 AM ETRead the release

Windward Bio listed on Nasdaq on November 13, 2026, pricing its IPO at $17.00 per share. The stock closed its first trading day at $28.50, up 68%, giving the clinical-stage immunology biotech a market cap of roughly $1.69 billion. Qiming Venture Partners, which invested from Series A through the IPO, authored the release and touted its 11th portfolio IPO of 2026.

Key figures

Offering Price
17
Ipo date
2026-11-13
First day pop
68%
First day close
28.5
Market cap approx
$1.69 billion

AI analysis

Red flags3 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.